Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
City of Hope Medical Center
City of Hope Medical Center
Emory University
National Institutes of Health Clinical Center (CC)
Atara Biotherapeutics
Memorial Sloan Kettering Cancer Center
AbbVie
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Northwestern University
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
University of Washington
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Asan Medical Center
National Cancer Institute (NCI)
Northwestern University
Northwestern University
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Boston University